Insurers see record earnings on ACA exchange plans in Q1 2017

Insurance companies earned an average of $298 per member in plans offered on the Affordable Care Act (ACA) marketplace in the first quarter of 2017, the best first quarter performance since the exchanges opened.

The Kaiser Family Foundation had previously found insurer financial performance worsened in 2014 and 2015, the first years of the new marketplace, but had showed signs of improvement in 2016. Medical-loss ratios—the share of premiums paid out as claims—averaged 75 percent in the first quarter of 2017, lower than ratios recorded in the first quarters of 2011, 2012 and 2013, before the exchanges were open. While loss ratios for the entire year will almost certainly be higher, the analysis said the early results bode well for insurer profitability on the exchanges in 2017.

“Insurer financial results show no sign of a market collapse,” the analysis said. “First quarter premium and claims data from 2017 support the notion that 2017 premium increases were necessary as a one-time market correction to adjust for a sicker-than-expected risk pool.”

Similar results were seen in other measures of financial performance. Average gross margins per member month was up to almost $100 in Q1 of 2017, compared to $48.13 in the same quarter last year, though this measure doesn’t account for administrative costs.

There was some concern that the double-digit hikes in premiums by exchange insurers would drive away healthier customers. Instead, the analysis found more evidence for the “one-time correction” argument, as premiums per enrollee grew 20 percent, but claims per person only went up 5 percent. The average number of days that individual market enrollees spent in the hospital during Q1 2017 ticked up only 1 percentage point to 24.7 percent.

“Taken together, these data on claims and utilization suggest that the individual market risk pool is relatively stable, though sicker on average than the pre-ACA market, which is to be expected since people with pre-existing conditions have guaranteed access to coverage under the ACA,” the analysis said.

The greater threat to market stability, Kaiser concluded, is uncertainty around cost-sharing reduction subsidies to insurers and enforcement of the individual mandate. Those factors have led some insurers to ask for larger premium increases for 2018 or exit the market altogether, which ACA opponents, like CMS Administrator Seema Verma, have used to argue the exchanges and the law itself are failing.

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.